Top Medical News
Pearl Toh, 17 hours ago

A novel light therapy which combines infrared, red and violet light emitted through LEDs* appears safe and improves the conditions of finger ulcers in patients with systemic sclerosis (SSc), a pilot study shows.

Stephen Padilla, 6 days ago
It appears that early short-term nutritional intervention with 100-percent whey-based partially hydrolysed formula (PHF-W) instead of standard cow’s milk formula (CMF) lowers the incidence of atopic dermatitis (AD) and costs for healthy, high-risk, nonexclusively breastfed infants in Singapore, reports a study.
07 Sep 2018
Hidradenitis suppurativa (HS) is associated with an increased risk of substance use disorder (SUD), according to a US study. Patients with HS may benefit from periodic screening for substance abuse.
Elaine Soliven, 06 Sep 2018
The combination of nivolumab and ipilimumab may improve rates of intracranial clinical benefit, complete response, and partial response in patients with melanoma, according to a recent study.
01 Sep 2018

QV Intensive with Ceramides
Ego Pharm Malaysia Sdn Bhd 

31 Aug 2018
New drug applications approved by US FDA as of 16 - 31 August 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
30 Aug 2018
Superficial chemical peel treatments are safe for darker skins, yielding relatively low complication rates, a recent study has shown. However, those with skin type VI are at higher risk of adverse events.
Special Reports
31 Jul 2018
A wound is a disruption of the normal structure and function of the epidermis. Wounds maybe caused by acute traumatic injury to the skin, or other aetiologies that cause initially intact skin to break down. Recently, Dato’ Dr Ho Teik Kok shared his insights into the importance of micronutrients for wound recovery, stressing on the importance of treating the underlying diseases that may impede wound healing.
Dr. Steven Ang, Dr. Leo Kah Woon, 11 Jul 2018
DCH Auriga recently held their first Aesthetics and Suturing Workshop under the IMPACT continuing medical education series – a scientific platform that aims to cascade the latest updates on disease management and share best clinical practices among healthcare professionals in Singapore. Two experts on aesthetics and aesthetic surgery shared their insights on suturing techniques and current approaches for scar prevention and management.
27 Dec 2017
The prevalence of allergic diseases in the Asia-Pacific region is expected to rise over the next 20 years, driven by rapid economic development and urbanization. Allergic diseases have high socioeconomic impact by impairing productivity and quality of life, and the impact may be greater in Asia-Pacific than in Europe due to the presence and predominance of perennial allergens.
22 Dec 2017
Eczema (atopic dermatitis) is a chronic inflammatory skin disease that can present in many different forms. However, it is principally characterized by dry skin, intense itching, and the presence of inflammatory skin lesions. [J Eur Acad Dermatol Venereol 2016;30:604-618; N Engl J Med 2008;358:1483-1494; Lancet 2016;387:1109-1122]
04 Dec 2017
At the 42nd Annual Dermatology Conference 2017 held recently in Kuala Lumpur, Professor Michael J. Cork spoke on the interaction between genetic and environmental factors as a primary event in the development of atopic dermatitis (AD) and highlighted the role of topical calcineurin inhibitors (TCIs) in the management of AD.
17 Aug 2017
The prevalence of atopic dermatitis (AD) in industrialized countries has increased exponentially over the past three decades, currently affecting 15 to 30% of children and up to 10% of adults.1 At the recent official launch event of pimecrolimus (Elidel®, Meda Healthcare Sdn. Bhd.) held at Le Méridien Kuala Lumpur, Professor Thomas Luger provided insights on the pathophysiology of AD and the role of topical calcineurin inhibitors (TCIs) in the management of AD. 
12 Apr 2017
CANESTEN HC – Clotrimazole 1% w/w and hydrocortisone 1% w/w cream – Bayer
Conference Reports
Stephen Padilla, 16 Aug 2018
An association exists between stress and quality of life (QoL) in patients with psoriasis vulgaris, according to a poster presented at the 23rd Asian-Australasian Regional Conference of Dermatology (RCD 2018) held in Surabaya, Indonesia.
Jairia Dela Cruz, 16 Aug 2018
Acidity of the skin appears to be significantly higher in atopic dermatitis (AD) patients than in controls without the condition, indicating that increased skin pH may heighten the risk of developing AD, according to a study.
Stephen Padilla, 15 Aug 2018
Most clinical guidelines recommend daily bathing in lukewarm water, followed by the application of moisturizers, in the treatment of atopic dermatitis (AD), according to an expert who presented at the 23rd Asian-Australasian Regional Conference of Dermatology (RCD 2018) held in Surabaya, Indonesia.
Jairia Dela Cruz, 15 Aug 2018
Managing paediatric atopic dermatitis remains a huge challenge mainly because of noncompliance to treatment, but this challenge can be addressed by prescribing nonsteroidal, noncalcineurin inhibitor agents providing epidermal repair therapy, according to an expert who spoke at the 23rd Asian Australasian Regional Conference of Dermatology (RCD 2018) held in Surabaya, Indonesia.
Tristan Manalac, 15 Aug 2018
Chronic pruritus is a diverse and aetiologically complex skin condition and thus requires a similarly comprehensive treatment approach, according to Dr Siti Aisah who gave a lecture at the recently concluded 23rd Regional Conference of Dermatology (RCD 2018) in Surabaya, Indonesia.
Tristan Manalac, 14 Aug 2018
Serum concentration of trace zinc appears to be correlated with premature canities, while trace ferrum and copper are not, according to a poster presented at the recently concluded 23rd Regional Conference of Dermatology (RCD 2018), in Surabaya, Indonesia.
Audrey Abella, 22 Mar 2018
Continued treatment with the anti-interleukin (IL)-23 monoclonal antibody guselkumab generated high efficacy response rates in patients with moderate-to-severe plaque psoriasis, according to findings from the ongoing phase III VOYAGE 2* trial presented at the 2018 American Academy of Dermatology Annual Meeting (AAD 2018) held in San Diego, California, US.